Ritter Pharmaceuticals Inc

Ritter Pharmaceuticals Inc is located in Los Angeles, United States on 1880 Century Park E #1000. Ritter Pharmaceuticals Inc is rated 5 out of 5 in the category pharmaceutical company in United States. Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) develops novel therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases. Its lead product, RP-G28, has the potential to become the first FDA-approved treatment for lactose intolerance, a condition that affects millions worldwide. The company is further exploring and translating the functionality gut microbiome changes may have on improving gut health and its therapeutic potential to treat/prevent a variety of gastrointestinal diseases.